Pacira BioSciences, Inc. (PCRX) — Business segments and KPIs
Revenue by business segment and geography for Pacira BioSciences, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 722.85M | 50.9% |
| EXPAREL | 575.13M | 40.5% |
| ZILRETTA | 116.63M | 8.2% |
| Bupivacaine Liposome Injectable Suspension | 6.91M | 0.5% |